Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|June 29, 2011
Novel therapeutic target for head and neck squamous cell carcinoma: HGF-MET signaling pathwayPatrick Chi-pan Lau, Anthony Tak-cheung Chan
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Epstein-Barr virus as a paradigm in nasopharyngeal cancer: from lab to clinicRadha Raghupathy, Edwin Pun Hui, Anthony Tak Cheung Chan
Rare Tumors|December 9, 2010
Complete small bowel obstruction caused by metastasis from primary nasopharyngeal carcinomaChi Pan Lau, Edwin Pun Hui, Anthony Tak-Cheung Chan
Head & Neck|November 23, 2011
Targeting tumor hypoxia in nasopharyngeal carcinomaBo Hong, Vivian Wai Yan Lui, Masumi Hashiguchi, et al.
American Journal of Cancer Research|February 18, 2016
Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC)Chi Hang Wong, Brigette Buig Yue Ma, Connie Wun Chun Hui, et al.
Journal of Applied Clinical Medical Physics|November 22, 2013
A novel compound 6D-offset simulating phantom and quality assurance program for stereotactic image-guided radiation therapy systemDennis Yuen Kan Ngar, Michael Lok-Man Cheung, Michael Koon-Ming Kam, et al.
American Journal of Cancer Research|June 24, 2015
Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC)Chi Hang Wong, Brigette Buig Yue Ma, Hio Teng Cheong, et al.
Cancer Medicine|August 10, 2013
Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancerAnne Tsao, Edwin Pun Hui, Rosalyn Juergens, et al.
In Vivo (Athens, Greece)|March 31, 2005
Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cellsFion Lan Sung, Terence Cheun Wai Poon, Edwin Pun Hui, et al.
Investigational New Drugs|December 17, 2009
Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activationBo Hong, Vivian W Y Lui, Edwin P Hui, et al.
Pageof 3